全部文献期刊学位论文会议报纸专利标准年鉴图书|学者科研项目
中外文文献  中文文献  外文文献
作者:Shun Morizumi , Shuichi Abe ...
来源:[J].Respiratory Research(IF 3.642), 2017, Vol.18 (1)Springer
摘要:Nintedanib, a tyrosine kinase inhibitor that is specific for platelet-derived growth factor receptors (PDGFR), fibroblast growth factor receptors (FGFR), and vascular endothelial growth factor receptors (VEGFR), has recently been approved for idiopathic pulmonary fibrosis. Fibroc...
作者:Shun Morizumi , Shuichi Abe ...
来源:[J].Experimental Lung Research(IF 1.465), 2019, Vol.45 (7), pp.188-199Taylor & Francis
摘要:Abstract(#br)Purpose/Aim of the Study:(#br) Wnt/β-catenin signaling was reported to be activated in pulmonary fibrosis, and was focused on as a target for antifibrotic therapy. However, the mechanism how the inhibition of Wnt/β-catenin signaling ameliorate pulmonary fibrosis...
作者:Shun Morizumi , Jun Minakuchi ...
来源:[J].Modern Rheumatology(IF 1.716), 2017, Vol.27 (5), pp.910-913Taylor & Francis
摘要:A 37-year-old pregnant woman developed purpura which was subsequently diagnosed as Henoch–Schönlein purpura (HSP). After childbirth, the patient developed proteinuria and hematuria. Further examination revealed that the HSP nephritis (HSPN) was associated with anti-threonyl-...
作者:Shun Morizumi , Shuichi Abe ...
来源:[J].2017, Vol.18 (1), pp.172BMC
摘要:Nintedanib, a tyrosine kinase inhibitor that is specific for platelet-derived growth factor receptors (PDGFR), fibroblast growth factor receptors (FGFR), and vascular endothelial growth factor receptors (VEGFR), has recently been approved for idiopathic pulmonary fibrosis. Fibroc...
作者:Shun Morizumi , Nobuhito Naito ...
来源:[J].Respiratory Investigation, 2019, Vol.57 (5), pp.435-443Elsevier
摘要:Abstract(#br)Background(#br)Systemic lupus erythematosus (SLE) commonly affects the lungs. However, the incidence of interstitial pneumonia (IP) related to SLE was reported to be about 10%, less than in the case of other connective tissue diseases, and the mechanism via which IP ...

我们正在为您处理中,这可能需要一些时间,请稍等。

资源合作:cnki.scholar@cnki.net, +86-10-82896619   意见反馈:scholar@cnki.net

×